HK1124263A1 - Treatment of development-related disorders - Google Patents

Treatment of development-related disorders

Info

Publication number
HK1124263A1
HK1124263A1 HK09103800.5A HK09103800A HK1124263A1 HK 1124263 A1 HK1124263 A1 HK 1124263A1 HK 09103800 A HK09103800 A HK 09103800A HK 1124263 A1 HK1124263 A1 HK 1124263A1
Authority
HK
Hong Kong
Prior art keywords
development
treatment
related disorders
disorders
Prior art date
Application number
HK09103800.5A
Other languages
English (en)
Inventor
Zhenglun Zhu
Hong Gao
Original Assignee
Zhenglun Zhu
Hong Gao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhenglun Zhu, Hong Gao filed Critical Zhenglun Zhu
Publication of HK1124263A1 publication Critical patent/HK1124263A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
HK09103800.5A 2006-02-22 2009-04-23 Treatment of development-related disorders HK1124263A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77564506P 2006-02-22 2006-02-22
PCT/US2007/062587 WO2007101063A2 (en) 2006-02-22 2007-02-22 Treatment of development-related disorders

Publications (1)

Publication Number Publication Date
HK1124263A1 true HK1124263A1 (en) 2009-07-10

Family

ID=38459733

Family Applications (2)

Application Number Title Priority Date Filing Date
HK09103800.5A HK1124263A1 (en) 2006-02-22 2009-04-23 Treatment of development-related disorders
HK18107362.5A HK1247943A1 (zh) 2006-02-22 2018-06-06 發育相關疾病的治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK18107362.5A HK1247943A1 (zh) 2006-02-22 2018-06-06 發育相關疾病的治療

Country Status (5)

Country Link
US (3) US7994126B2 (xx)
EP (2) EP1991246B1 (xx)
CN (2) CN101505780B (xx)
HK (2) HK1124263A1 (xx)
WO (1) WO2007101063A2 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008133945A1 (en) * 2007-04-25 2008-11-06 The Trustees Of The University Of Pennsylvania Low level fluorescence detection at the light microscopic level
HUE042736T2 (hu) * 2009-07-15 2019-07-29 Zhenglun Zhu Gyulladásos vagy autoimmun rendellenességek kezelésének irányítása HOM-1 kifejezés alkalmazásával
JP2012197230A (ja) * 2009-07-29 2012-10-18 Tokyo Medical & Dental Univ 抗腫瘍剤
CN103415615B (zh) * 2010-11-24 2015-11-25 高红 扩增造血干细胞
US10066272B2 (en) * 2011-06-10 2018-09-04 Zhenglun Zhu Human homeobox gene ventx and macrophage terminal differentiation and activation, compositions and methods thereof
US9428748B2 (en) 2013-06-17 2016-08-30 Hong Gao Method of expanding hematopoietic stem cells
US11268095B2 (en) * 2016-02-04 2022-03-08 Zhenglun Zhu Treatment and diagnosis of inflammatory disorders
CN107236728A (zh) * 2017-06-16 2017-10-10 天津市肿瘤医院 一种提取动物细胞核内染色质及其相关蛋白的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US6159462A (en) 1996-08-16 2000-12-12 Genentech, Inc. Uses of Wnt polypeptides
US6824971B1 (en) 1997-07-01 2004-11-30 Sloan-Kettering Institute For Cancer Research Methods of inhibiting or enhancing the TGFβ-SMAD signaling pathway
US6165748A (en) 1997-07-11 2000-12-26 Genetics Institute, Inc. Frazzled nucleotide sequences and expression products
AU784513B2 (en) 2000-01-18 2006-04-27 Board Of Trustees Of The Leland Stanford Junior University Expansion of stem and progenitor cells by beta-catenin
US6436703B1 (en) 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
US6544962B1 (en) * 2000-11-02 2003-04-08 Matrix Pharmaceutical, Inc. Methods for treating cellular proliferative disorders
WO2004072279A2 (en) * 2003-02-07 2004-08-26 Novozymes A/S Proteases
US20060247193A1 (en) * 2003-02-10 2006-11-02 National Institute Of Advanced Industrial Science And Technology Regulation of gene expression by dna interference
JPWO2005010180A1 (ja) * 2003-07-23 2006-09-07 北海道ティー・エル・オー株式会社 ホメオボックス遺伝子の発現による癌の判定方法

Also Published As

Publication number Publication date
US20110300549A1 (en) 2011-12-08
CN101505780A (zh) 2009-08-12
CN107446033A (zh) 2017-12-08
WO2007101063A3 (en) 2008-11-06
EP1991246A2 (en) 2008-11-19
EP1991246B1 (en) 2013-09-11
WO2007101063A2 (en) 2007-09-07
CN101505780B (zh) 2017-06-13
US8993227B2 (en) 2015-03-31
EP1991246A4 (en) 2010-02-17
CN107446033B (zh) 2022-04-01
HK1247943A1 (zh) 2018-10-05
US20080032927A1 (en) 2008-02-07
US20130280261A1 (en) 2013-10-24
US7994126B2 (en) 2011-08-09
EP2612675A1 (en) 2013-07-10

Similar Documents

Publication Publication Date Title
HK1247943A1 (zh) 發育相關疾病的治療
EP1981526A4 (en) ADIPONECTIN FOR THE TREATMENT OF VARIOUS DISORDERS
IL197001A0 (en) Combination treatment for metabolic disorders
EP2010187A4 (en) CONNECTIONS FOR DISEASES AND FUNCTIONAL DISORDERS
GB0624874D0 (en) Treatment
IL195906A0 (en) Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
IL193936A0 (en) Compositions and methods for the treatment of immunoinflammatory disorders
IL194189A0 (en) Combination treatment of metabolic disorders
GB0600692D0 (en) Well treatment
ZA200901523B (en) Use of extracts for the treatment of viral disorders
EP1996218A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
IL205578A0 (en) Aldh-2 inhibitors in the treatment of psychiatric disorders
EP2077838A4 (en) METHODS FOR TREATING A-RELATED DISORDERS AND COMPOSITIONS THEREFOR
ZA201000225B (en) Treatment of depression
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
GB0607952D0 (en) Novel treatment
PL1982178T3 (pl) Sposoby leczenia zaburzeń afektywnych
GB0723100D0 (en) Treatment of HFnEF
IL194798A0 (en) Treatment of melanoma
GB0604460D0 (en) Treatment
GB0602857D0 (en) The treatment of sialorrhoea
GB0624439D0 (en) Technique for treatment of gall-and kidney-stones
HK1145282A1 (en) Treatment of sleep disorders
GB0602855D0 (en) The Treatment Of Sialorrhoea
GB0602858D0 (en) The treatment of sialorrhoea